RU2070405C1 - Diagnosis and adaptive therapy device - Google Patents

Abstract

FIELD: medicine; medical equipment. SUBSTANCE: device is applicable to register and analyze electric characteristics of the bio-active points (BAT) and bio-active zones (BAZ) of the skin. It is also designed to assess the general health condition and select most appropriate individual treatment tools. The device has two drug selectors. The first selector keeps an electronic track of the homeopathic and organic drug doses, etc., the other records electronic copies of the drug treatment and BAT and BAZ data at the user's will. The device also allows for transferring the electronic drug treatment copies with desired changes in the potential to secondary carriers. Besides, the device is applicable for the purposes of adaptive electric puncture and biological resonance therapy. EFFECT: shorter medical check period; higher diagnosis reliability; enhanced therapy effect. 6 cl, 8 dwg

Description

 The invention relates to medical equipment and can be used for registration and analysis of electrical parameters of biologically active points (BAP) and biologically active zones (BAS) of the skin, health status assessment and selection of individual means of exposure to the body.

A known device for diagnosing the electrical conductivity of the skin and selecting means of influencing the body, in which the signal from the test circuit with the electrode block enters the conductivity meter, the level of which is recorded by the measuring device [1]
As a prototype, a device containing a test circuit with a block of electrodes, a measuring device, memory units, a control unit and a signal switch [2]
The aim of the invention is to reduce examination time, increase the reliability of diagnosis and the effectiveness of therapy due to the use of two drug selectors in the device: the first stores an electronic copy of homeopathic medicines, nasodes, organ preparations, etc. the second is used for storing current electronic copies of drugs and information from BAT and BAZ, which are entered at the request of the user. In addition, the device allows the transfer of electronic copies of selected drugs with the desired change in potency on secondary carriers, as well as adaptive electro-puncture and bioresonance therapy.

 This is achieved due to the fact that a diagnostic unit and adaptive therapy unit containing an electrode block with a switching unit and a control unit and a computer interface include: a unit for changing resonant characteristics, a digital-to-analog conversion unit, a measurement unit, and medical selector blocks of the first and second . In this case, the input / output of the unit for changing the resonant characteristics is connected to the corresponding input / output of the switching unit and to the input / output of both drug selectors, the input of the measurement unit is connected to the corresponding output of the switching unit, the output of the digital-to-analog converter is connected to the corresponding input of the switching unit, the information output the bus of the control unit and the interface with the computer is connected to the inputs of the information bus of the blocks: switching, measurements, digital-to-analog converter, changes in resonant character teristik, the first and second medical selectors; the control outputs of the control unit and the computer interface are connected to the corresponding control inputs of the blocks: switching, measurements, digital-to-analog converter, changing the resonance characteristics, the first and second drug selectors, the additional output of the analog-to-digital converter is connected to the corresponding input of the control and computer interface ; the input / output of the control unit and the interface with the computer is designed to connect to a computer.

 In FIG. 1 shows a structural diagram of a diagnostic device and adaptive therapy; in FIG. 2 switching unit; in FIG. 3 block of measurements; in FIG. 4 block digital-to-analog converter; in FIG. 5 block changes in resonant characteristics; in FIG. 6 first drug selector; in FIG. 7 second drug selector; in FIG. 8 control unit and computer interface.

 The diagnostic and adaptive therapy device (Fig. 1) comprises an electrode unit 1 connected to a switching unit 2, an input measuring unit 3 connected to a corresponding output of a unit 2, a digital-to-analog converter unit 4 connected to a corresponding input of a unit 2; unit 5 for changing resonant characteristics, the first drug selector 6 and the second drug selector 7 connected to each other and to the corresponding input / output of unit 2. The input / output of the control and computer interface unit 8 is connected to the computer; the output of the information bus of block 8 is connected to the inputs of the information bus of blocks 2-7 for transmission to the inputs of the control registers of blocks 2-7 of the control words received from the computer; the outputs of the control signals of block 8 are connected to the corresponding inputs of the control signals of blocks 2-7 for overwriting control information from the bus into the registers of blocks 2-7; the control output of block 3 is connected to the corresponding input of block 8.

 The switching unit 2 (Fig. 2) contains a control register 9 and a digital-controlled analog signal commutator 10. The control information recorded from the information bus 11 by the control signal 12 to the control register is transmitted to the switch connecting its inputs / outputs 13 intended for communication with the block of electrodes 1 (Fig. 1) with inputs / outputs 14.15 and 16, in turn connected to blocks 3.4 and 5-7, respectively, according to the control information previously recorded in the register 9.

 The measurement unit (Fig. 3) contains a control register 17, a digital-to-analog converter 18, a comparator 19, an amplifier 20, a reference voltage generator 21, and a measuring device 22. The control information recorded from the information bus 23 by the control signal 24 to the control register is transmitted to digital-to-analog converter. The output of the latter is connected to one of the inputs of the comparator 19, the second input of which is connected to the output of the amplifier 20; the output of the latter is also connected to the input of the measuring device. The input of the unit is a two-wire line 25; the first is connected to the input of the amplifier 20, the second to the output of the reference voltage generator 21; this line is connected to the corresponding output of the switching unit 2 (figure 1). The signal 26 from the output of the comparator 19 is transmitted to the control input of the control unit and the interface with the computer 8 (figure 1).

 The digital-to-analog conversion unit (Fig. 4) contains a control register 27, a digital-to-analog converter 28, two inverting amplifiers 29 and 30. The control information recorded from the information bus 31 by the control signal 32 to the control register is transmitted to the digital-to-analog converter . The output of the latter is connected to the input of the first amplifier 29, the output of which is connected to the input of the second amplifier 30. The outputs of both amplifiers form a two-wire line 33, which is the output of the unit and connected to the corresponding input of the switching unit 2 (Fig. 1).

 The unit for changing resonant characteristics (Fig. 5) contains a control register 34, a resonant characteristics converter 35, a physiological and pathological electromagnetic oscillations recorder and a transfer to secondary carriers 36. The control information recorded from the information bus 37 by the control signal 38 to the control register is transmitted to a transducer 35 connected to a recorder of physiological and pathological electromagnetic oscillations and transfer to secondary carriers 36. The output of the transducer forms two odnuyu line 39 is an input / output unit, which in turn is connected to the corresponding input / output switching unit 2 (Figure 1).

 The first drug selector (Fig.6) contains a control register 40, a memory element 41 and an analog multiplexer 42. The control information recorded from the information bus 43 by the control signal 44 to the control register is transmitted to the control inputs of the memory element and multiplexer, which determines the choice of electronic copies of the drug and connection to the communication line 45 of the output of the analog multiplexer 42. The output of the latter forms a two-wire line 45, which is the input / output of the unit, which in turn is connected with the corresponding input / output of the switching unit 2 (Fig. 1), as well as the input / output of the unit for changing the resonant characteristics 5.

 The second drug selector (Fig. 7) contains a control register 46, a memory element 47, an analog multiplexer 48, and a shaper of the write signal 49. The control information recorded from the information bus 50 by the control signal 51 to the control register is transmitted to the control inputs of the memory element 47, a multiplexer 48 and a shaper of the recording signal 49, which determines the choice of the transfer location of an electronic copy of the drug or information from the BAT or BAZ, connecting an analog multiplexer 48 to the communication line 52 and initializing transferring an electronic copy to the storage element 47. The output of the shaper of the recording signal 49 is connected to the corresponding control input of the storage element 47. The output of the multiplexer 48 forms a two-wire line 52, which is the input / output of the unit, which in turn is connected to the corresponding input / output of the switching unit 2 ( figure 1), as well as with the input / output of the unit for changing the resonant characteristics 5 and with the input / output of the first drug selector 6.

 The control unit and the computer interface (Fig. 8) contains a communication register 53, a decoder of control commands 54. From the computer in a serial code, control information is transmitted via a communication line 55, which is gated by a signal on line 56. A part of the information word is transmitted via bus 58 to decryption in decoder 54. The signal on the communication line with the computer 57 is the gating of the transmitted information on the bus 58 to generate control signals 61-66 blocks 2-7 (Fig. 1) and tracking control information on the bus 59 (Fig. 8) for transmission to blocks 2-7 (figure 1). The output of the information bus 59 (Fig. 8) is connected to the inputs of the information bus of blocks 2-7 (Fig. 1), i.e. output 59 (Fig. 8) with inputs: 11 (Fig. 2), 23 (Fig. 3), 31 (Fig. 4), 37 (Fig. 5), 43 (Fig. 6), 50 (Fig. 7 ) The outputs of the control signals of block 8 (Fig. 1) are connected to the inputs of the control signals of blocks 2-7 as follows: the output of the control signal 61 (Fig. 8) is connected to the input of the control signal 12 (Fig. 2), 62 (Fig. 8), with 24 (FIG. 3), 63 (FIG. 8) with 32 (FIG. 4), 64 (FIG. 8) with 38 (FIG. 5), 65 (FIG. 8) with 44 (FIG. 6), 66 (Fig. 8) with 51 (Fig. 7).

 The diagnostic and adaptive therapy device operates in the following main modes: BAT search; taking indications in BAT and BAZ and diagnostics; drug testing of BAT and BAS; transfer of electronic copies of selected drugs to secondary carriers and a change in potency; adaptive electropuncture therapy according to BAP and BAS; adaptive bioresonance therapy for BAP and BAS; recording electronic copies from BAT and BAZ to a secondary medium.

 All modes of operation of the device are set by entering control information into the control unit and combining it with a computer 8 (Fig. 1), generated by software on a computer and then distributing it among blocks 2-7 (Fig. 1). Initially, all blocks 2-7 are set to their initial state by entering the necessary initial information into the control registers of the blocks by the method of sequential generation of information signals: 61 (Fig. 8) for the switching block. 62 for the measurement unit, 63 for the digital-to-analog converter unit, 64 for the unit for changing the resonance characteristics, 65 for the first drug selector and 66 for the second drug selector if there are corresponding control words on bus 59 for each of units 2-7 (Fig. 1 ) In the initial state, blocks 2-7 are disconnected from the electrode block 1, and blocks 5, 6 and 7 from the switching block 2, i.e. from the communication line with block 2. In the BAP search mode in the diagnostic and adaptive therapy device (Fig. 1), the selected pair of electrodes from the block of electrodes 1 is connected through the switching unit 2 to the meter block 3. This connection is made and the search for BAP is performed as follows : in the control register 9 (Fig. 2) of the switching unit via the information bus 211 connected to the output of the bus 59 (Fig. 8) and by the control signal 12 (Fig. 2) coming from the control and computer interface (Fig. 8 ) from line 61, the control word is written, which is transmitted further from the output of the register 9 (Fig. 2) to the control input of the switch 10, which determines the selection of the required pair of electrodes (passive and active measuring electrodes) from block 1 (Fig. 1) and the connection of this pair through the communication line 13 (Fig.2) by the switch 10 to the communication line 14 and connecting to the input of the measurement unit 3 (figure 1), i.e. to line 25 (figure 3). The signal from the resulting circuit (reference voltage generator 21 (Fig. 3), communication line 25, communication line 14 (Fig. 2), switch 10, communication line 13, passive electrode, patient’s hand, skin in the area of the BAP, active electrode, communication line 13, switch 10, communication line 14, communication line 25 (Fig. 3) is fed to the input of amplifier 20. From the output of amplifier 20, the received signal is transmitted to the input of measuring device 22, as well as to one of the inputs of comparator 19. From the information bus 23, connected to the output of the bus 59 (Fig.8) of the control unit and the interface with the computer 8 (Fig.1) in regis p control 17 (Fig. 3) by the control signal 24 coming from the control unit and the computer interface (Fig. 8) from line 62, a control word is recorded. Next, the control word from the output of register 17 (Fig. 3) is transmitted to the digital input -analog converter 18. The voltage potential generated in this way at the output of the digital-to-analog converter 18 is fed to the other input of the comparator 19. The logic signal for comparing the potentials received at the output of the comparator 19 is transmitted through the control line 26 through the control and interface unit with a computer 8 (Fig. 1) to a communication line 60 (Fig. 8) in a computer. According to the sequential approximation algorithm, taking into account the logical control signal 26 from the measurement unit 3 (Fig. 3), the digitalization of the measured signal takes place in the computer. Monitoring the search for BAT is carried out according to the indications on the indicator of the measuring device 22 (Fig. 3). The maximum value of the reading of the device corresponds to the hit of the active electrode probe on the BAP. The search result is also displayed on the computer monitor screen and is duplicated by a sound signal on a standard computer buzzer. Upon completion of the search for the BAT, the switching unit 2 (Fig. 2) and the measuring unit 3 are returned to their initial state.

 In the BAT, BAZ and diagnostic mode, the electrical conductivity of the skin with the BAT and BAZ is measured, for which the necessary pairs of electrodes and the readings are selected depending on the measurement methods used. In particular, the measurement can be carried out with direct current of various polarity and / or magnitude, as well as in a dynamic mode on transients. The selection of the required pair of electrodes and their connection to the measurement unit is carried out in the same sequence as the BAP search mode, except that when taking readings on the BAZ, the pair of electrodes with a large surface necessary for this method is selected.

 In the mode of taking readings in the BAT and BAZ in the diagnostic and adaptive therapy device (Fig. 1), the selected pair of electrodes from the block of electrodes 1 is connected through the switching unit 2 to the block of the meter 3. The device is switched to the operating mode for taking readings in the BAT and BAZ as follows: in the control register 9 (Fig. 2) of the switching unit via the information bus 11 connected to the output of the bus 59 (Fig. 8) and by the control signal 12 (Fig. 2) coming from the control unit and the computer interface (Fig. .8) from line 61, the control word is recorded, transferred further from the output of the register 9 (FIG. 2) to the control input of the switch 10, which determines the selection of the required pair of electrodes (passive and active measuring electrodes) from block 1 (FIG. 1) and the connection of this pair through the communication line 13 (FIG. 2) ) through the switch 10 to the communication line 14 and connecting to the input of the measurement unit 3 (figure 1), i.e. to line 25 (figure 3). As a result of this sequence of actions, in particular, when taking readings in the BAT, a measurement circuit is formed of the reference voltage generator 21 (Fig. 3), communication line 25, communication line 14 (Fig. 2), switch 10, communication line 13, passive electrode , patient's arm, BAP, active electrode, communication line 13, switch 10, communication line 14, communication line 25 (Fig. 3). When taking readings in the BAZ, in particular on the leg-to-leg leads, the passive electrode is connected to the foot of one of the legs, and the active electrode to the foot of the other leg. The readings from the resulting circuit are carried out in the same sequence as in the BAT search mode, i.e. from the output of the amplifier 20 (Fig. 3), the received signal is transmitted to the input of the measuring device 22, as well as to one of the inputs of the comparator 19. From the information bus 23 connected to the output of the bus 59 (Fig. 8) of the control unit and computer interface 8 ( Fig. 1) in the control register 17 (Fig. 3) by the control signal 24 coming from the control unit and the computer interface (Fig. 8) from line 62, the control word is recorded. Next, the control word from the output of the register 17 (Fig. 3) is transmitted to the input of the digital-to-analog converter 18. The voltage potential thus formed at the output of the digital-to-analog converter 18 is supplied to the other input of the comparator 19. The logical signal comparing the potentials received at the output of the comparator 19 its inputs are transmitted along the control line 26 through the control unit and the interface with the computer 8 (Fig. 1) to the communication line 60 (Fig. 8) in the computer. According to the sequential approximation algorithm, taking into account the logical control signal 26, from the measurement unit 3 (Fig. 3), the computer digitizes the measurement results. The current measurement results are displayed on the indicator of the measuring device 22 (figure 3) and on the screen of the computer monitor, and is duplicated by the level of the sound signal on a standard computer buzzer. Based on the measurement results in accordance with the algorithms laid down in the program, diagnostic problems are solved. Upon completion of the measurements in the BAT and BAZ, the switching unit 2 (Fig. 1) and the measuring unit 3 are returned to their initial state.

 In the mode of drug testing, one or a set of stored electronic copies of drugs intended for drug testing and / or therapeutic exposure are selected in software, which are introduced into the measurement circuit by connecting the input / output line of the first drug selector to the desired electrode via the switching unit. Based on the results of taking readings from the BAT and / or BAS from the resulting measurement circuit, with the electronic copy of the drug entered into it, the patient’s effect is evaluated. During drug testing of BAS, the required pair of electrodes with a large surface is selected from the electrode block.

 The transfer of the device into the operating mode for drug testing is performed as follows: in the control register 9 (Fig. 2) of the switching unit via the information bus 11 connected to the output of the bus 59 (Fig. 8) and by the control signal 12 (Fig. 2) coming from the control unit and the computer interface (Fig. 8) from line 61, a control word is written, which is transmitted further from the output of register 9 (Fig. 2) to the control input of the switch 10, which determines the choice of the required pair of electrodes (passive and active measuring electrodes) from block 1 (figure 1) and under connecting this pair over the communication line 13 (FIG. 2) by means of a switch 10 to the communication line 16 and connecting to the input / output of the first drug selector 6 (FIG. 1), i.e. to line 45 (Fig.6). The control word is recorded in the control register 40 of the first drug selector via the information bus 43 connected to the output of the bus 59 (Fig. 8) and by the control signal from line 65 coming to the control line 44 (Fig. 6), which is transmitted further from the output of the register control 40 to the control inputs of the storage element 41 and the analog multiplexer 42, thereby determining the choice of the necessary electronic copy of the drug selected for testing and connecting the analog multiplexer 42 to line 45. As a result of this sequence In the course of action, a measurement loop is formed of the reference voltage generator 21 (Fig. 3), communication line 25, communication line 14 (Fig. 2), switch 10, communication line 16, communication line 45 (Fig. 6), analog multiplexer 42, memory element with an electronic copy of the selected drug 41, analog multiplexer 42, communication line 45, line 16 (Fig. 2), switch 10, communication line 13, passive electrode, patient's arm, BAP, active electrode, communication line 13, switch 10 communication line 14 , communication line 25 (figure 3). During medical testing of BAS, in particular, on the leads "arm-arm" the passive electrode is connected to the palm of one of the hands. and active to the palm of the other hand. The signal from the resulting circuit is fed to the input of the amplifier 20. The readings from the formed circuit are performed in the same sequence as in the reading mode in the BAT and BAZ, i.e. from the output of amplifier 20, the received signal is transmitted to the input of the measuring device 22, as well as to one of the inputs of the comparator 19. From the information bus 23 connected to the output of the bus 59 (Fig. 8) of the control unit and computer interface 8 (Fig. 1), in the control register 17 (Fig.3) by the control signal 24 coming from the control unit and the computer interface (Fig.8) from line 62, the control word is recorded. Next, the control word from the output of the register 17 (Fig. 3) is transmitted to the input of the digital-to-analog converter 18. The voltage potential thus formed at the output of the digital-to-analog converter 18 is supplied to the other input of the comparator 19. The logical signal comparing the potentials at the output of the comparator 10 its inputs are transmitted along the control line 26 through the control unit and the interface with the computer 8 (Fig.1) to the communication line 60 (Fig.8) in the computer. According to the sequential approximation algorithm, taking into account the logical control signal 26, from the measurement unit 3 (Fig. 3), the computer digitizes the measurement results. The replacement of the control word in the register 40 (Fig.6) is the replacement of an electronic copy of the drug with electronic copies of other drugs to continue drug testing, but using another drug. The current measurement results are displayed on the indicator of the measuring device 22 (Fig. 3) and on the screen of the computer monitor and are duplicated by the sound signal level on the standard computer buzzer. Based on the results of measuring indicators in BAP and BAZ, an assessment is made of the effectiveness of the effect of this drug on the patient. Upon completion of the drug testing of BAT and BAZ, the switching unit 2 (Fig. 1), the measuring unit 3 and the first drug selector 6 are returned to their initial state.

 The device can transfer selected electronic copies of drugs during drug testing with a change in potency to achieve the optimal effect of the drug according to preliminary diagnostic indications with BAT and BAS for a particular patient. The transfer of electronic copies is possible on secondary media or in a second drug selector in order to use the resulting copies for subsequent therapeutic exposure.

 The transfer of the device to the operating mode of transferring an electronic copy of selected drugs to secondary carriers with a change in the potency of the drug is as follows. In the control register 40 (Fig.6) of the first drug selector via the information bus 43 connected to the output of the bus 59 (Fig. 8) and by the control signal 44 (Fig.6) coming from the control unit and the computer interface (Fig.8 ) from line 64, a control word is written, which is transmitted further from the output of register 40 (Fig. 6) to the control input of the memory element 41 and to the control input of the analog multiplexer 42 to select an electronic copy of the required preparation and connect the input / output of the analog multiplexer 42 to the communication line 45, in managing regis mp 34 (FIG. 5) of the unit for changing the resonant characteristics 5 (FIG. 1) via the information bus 37 (FIG. 5) connected to the output of the bus 59 (FIG. 8) and by the control signal 38 (FIG. 5) coming from control unit and a computer interface (Fig. 8) from line 64, a control word is written, which is transmitted further to the control input of the resonant characteristics converter 35 (Fig. 5), i.e. to line 45 (Fig. 6), as well as the initialization of the transfer of an electronic copy of the selected drug from the first drug selector, and if necessary, the level of change in the potency of the drug, on a secondary carrier, previously placed inside the registrar of physiological and pathological electromagnetic waves and transfer to secondary carriers 36. Upon completion of work on transferring electronic copies of selected drugs to secondary carriers, the unit for changing the resonance characteristics 5 (Fig. 1) and the first drug selector 6 trans dress in the initial state.

 In the device, the operating mode of adaptive electropuncture therapy is possible to achieve optimal exposure according to preliminary diagnostic indications in the BAP and BAS for a particular patient. Adaptive electro-puncture therapy mode is carried out under the control of hardware-software feedback formed by switching units, measurements and a digital-to-analog converter, and implemented by software diagnostic algorithms. The device is put into adaptive electro-puncture therapy operation mode as follows: in the control register 9 (Fig. 2) of the switching unit via the information bus 11 connected to the output of the bus 59 (Fig. 8) and by the control signal 12 (Fig. 2) coming from the control unit and the computer interface (Fig. 8) from line 61, the control word is written, which is transmitted further from the output of register 9 (Fig. 2) to the control input of the switch 10, which determines the choice of the necessary pair of therapeutic electrodes (passive and active) from block 1 (figure 1) and subs union of the pair of link 13 (Figure 2) via a switch 10 to the link 15 and the connection to the output of the block digital-analog converter 4 (Figure 1), i.e. to the communication line 33 (Fig. 4), from the information bus 31 by a control signal 32 coming from the control unit and the computer interface (Fig. 8) from line 63, a control word is recorded that determines the operation mode of the unit, i.e., the amplitude and the polarity of the output signal from the digital-to-analog converter 28, transmitted further from the output of the register 27 (Fig. 4) to the control input of the digital-to-analog converter 28, from the output of which the signal is transmitted to the input of the first inverting amplifier 29, from the output of the last signal is transmitted to the first communication wire 33 and on in the course of the second inverting amplifier 30, from the output of the latter to the second wire of the communication line 33. By changing the control word recorded in the control register 27, the output signal is changed in amplitude and sign, the rate of change of the amplitude-sign indicators of the output signal determines its frequency and spectral indicators. Upon completion of the work on adaptive electro-puncture therapy, the digital-to-analog conversion unit 4 (Fig. 1) and the switching unit 2 are returned to their initial state.

 In the device, the operating mode of adaptive bioresonance therapy is possible to achieve optimal exposure according to preliminary diagnostic indications in the BAT and BAS for a particular patient. Adaptive bioresonance therapy mode is carried out under the control of hardware-software feedback formed by switching, measurement and adaptive bioresonance therapy units, and implemented by software diagnostic algorithms. The functions performed by the device in this mode are: assessment of the spectral characteristics of the patient's own physiological and pathological electromagnetic waves; filtering out the components of electromagnetic waves; the allocation of physiological and pathological components and the return to the patient's body with a certain amplitude and phase, and in certain proportions to suppress pathological fluctuations and enhance physiological.

 The transfer of the device into the operating mode of adaptive bioresonance therapy is as follows. In the control register 9 (Fig.2) of the switching unit via the information bus 11 connected to the output of the bus 59 (Fig.8) and by the control signal 12 (Fig.2) coming from the control unit and the computer interface (Fig.8) from line 61, the control word is written, which is transmitted further from the output of register 9 (Fig. 2) to the control input of the switch 10, which determines the selection of the necessary pair of therapeutic electrodes (passive and active) from block 1 (Fig. 1) and the connection of this pair by the communication line 13 (Fig. 2) through the switch 10 to the communication line 16, i.e. connecting to the input / output unit for changing the resonant characteristics 5 (Fig. 1), to the communication line 39 (Fig. 5), from the information bus 37 (Fig. 5) by the control signal 38 coming from the control unit and the computer interface (Fig. .8) from line 65, a control word is recorded that determines the operation mode of the unit, transmitted further from the output of register 34 (Fig. 5) to the control input of the resonant characteristics converter 35, and the input / output of the latter is connected to communication line 39, and, respectively, to the communication line of the switching unit 16 (Fig. 2). Upon completion of the adaptive bioresonance therapy, the unit for changing the resonant characteristics 5 (Fig. 1) and the switching unit 2 are returned to their initial state.

 The device can transfer information about physiological and pathological fluctuations, as well as selected electronic copies of the BAT and BAZ. The transfer of electronic copies is possible on secondary carriers and / or in the second drug selector in order to use the obtained copies for subsequent therapeutic treatment or comparison.

 The transfer of the device to the operating mode of transferring an electronic copy from the BAT and BAZ to secondary media is as follows. In the control register 9 (Fig.2) of the switching unit via the information bus 11 connected to the output of the bus 59 (Fig.8) and by the control signal 12 (Fig.2) coming from the control unit and the computer interface (Fig.8) from line 61, the control word is written, which is transmitted further from the output of register 9 (Fig. 2) to the control input of the switch 10 determining the connection of the selected pair of electrodes connected to the BAT or BAZ, via communication line 13 through switch 10 to communication line 16, i.e. e. to the communication line 52 (Fig. 7) to the input / output of the second drug selector 7 (Fig. 1), to the communication line 52 (Fig. 7) and to the communication line 39 (Fig. 5) to the input / output of the unit for changing resonant characteristics 5 (Fig. 1), into the control register 46 (Fig. 7) of the second drug selector via the information bus 50 connected to the output of the bus 59 (Fig. 8) and by the control signal 51 (Fig. 6) coming from the control unit and computer interface (Fig. 8) from line 66, the control word is written, which is transmitted further from the output of the register 46 (Fig. 7) to the control input of the memory element 47 and to control progress of the analog multiplexer 48 to select a location on the storage element for transferring an electronic copy from the BAT or BAZ and connect the input / output of the analog multiplexer 48 to the communication line 52, as well as to the control input of the recording signal generator 49 to initiate the transfer mode of the electronic copy of the BAT or BAZ to the storage element 47. When entering the control word into the control register 34 (Fig. 5) of the unit for changing the resonant characteristics 5 (Fig. 1) via the information bus 37 (Fig. 5) connected to the output of the bus 59 (Fig. 8) and signal at the control 38 (Fig. 5) coming from the control unit and the computer interface (Fig. 8) from the line 65, transmitted further from the output of the register 34 (Fig. 5) to the control input of the resonant characteristics converter 35. As a result, the input is connected / output of the latter to communication line 39 and initialization of transfer of an electronic copy from the BAT or BAZ to a secondary medium previously entered into the physiological and pathological electromagnetic waves recorder and transfer to a secondary medium 36. Upon completion of work on recording electronic copies from BAT or BAZ on secondary carriers, the unit for changing the resonant characteristics 5 (Fig. 1), the second drug selector 7, and the switching unit 2 are reset.

 In the diagnostic and adaptive therapy device, the combination or complex use of the operating modes is possible in order to achieve the optimal diagnosis and therapeutic effect on the patient, while the combination of operating modes is possible both with time division and spatial division, i.e. by alternately switching operating modes or using different pairs of electrodes from the electrode block to simultaneously conduct a therapeutic effect and take readings from the BAT and / or BAS to select the optimal therapeutic effect.

Claims (6)

 1. A device for diagnostics and adaptive therapy, containing a block of electrodes, a switching unit, a memory unit, a control unit and a computer interface, and a switching unit is connected to the electrode unit, characterized in that a unit for changing resonant characteristics, a digital-to-analog conversion unit, the measurement unit, the first and second medical selectors, while the input-output of the unit for changing the resonant characteristics is combined with the corresponding inputs and outputs of the switching unit and the first and second medical villages Ktorov, the output of the digital-to-analog conversion unit is connected to the corresponding input of the switching unit, the input of the measuring unit with the corresponding output of the switching unit, and the control output of the measurement unit is connected to the control input of the control unit and the computer interface, the output of the information bus of which is connected to the information inputs of the switching unit, unit changes in the resonance characteristics of the digital-to-analog conversion unit and the first and second drug selectors, in addition, the control outputs of the unit are controlled The computer interfaces and interfaces are connected to the corresponding control inputs of the switching unit, the unit for changing the resonant characteristics, the digital-to-analog conversion unit, and the first and second drug selectors.  2. The device according to claim 1, characterized in that the switching unit comprises a digitally controlled analog signal switch and a control register, the information input of which is the information input of the switching unit, the control input is the control input of the switching unit, and the output is connected to the control inputs of the analog signal switch with digital control, the first input-output of which is the input-output for connecting to the electrode block, the second input-output input-output for connecting to the input-output of the change unit In addition to the resonance characteristics of both the first and second drug selectors, the input is an input for connecting to the output of the digital-to-analog conversion unit, and the output is an output for connecting to the input of the measurement unit.  3. The device according to claim 1, characterized in that the unit for changing resonant characteristics contains a control register, the information input of which is the information input of the unit for changing resonant characteristics, the control input is for the control input of the unit for changing resonant characteristics, the output of the control register is connected to the control input of the resonant characteristics converter the control output of which is connected to the control input of the recorder of physiological, pathological electromagnetic waves and trans wasp to secondary carriers, while the outputs of the resonant characteristics converter are the input-output of the block of changes in the resonant characteristics.  4. The device according to claim 1, characterized in that the digital-to-analog conversion unit contains a control register, the information input of which is the information input of the digital-to-analog conversion unit, and the control input is the control input of the digital-to-analog conversion unit, the output of the control register is connected to the control input of the digital-to-analog converter, the output of which connected through the first inverting amplifier to the input of the second inverting amplifier, while the outputs of the first and second inverting amplifiers Ithel are output digital to analog conversion unit.  5. The device according to claim 1, characterized in that the first drug selector contains a control register, the information input of which is the information input of the first drug selector, the control input is the control input of the first drug selector, the first and second outputs are connected to the control inputs of the memory element and an analog multiplexer, the other input of which is connected to the output of the storage element, while the outputs of the analog multiplexer are the input-output of the first m dikamentoznogo selector.  6. The device according to claim 1, characterized in that the second drug selector contains a control register, the information input of which is the information input of the second drug selector, the control input is the control input of the second drug selector, and the output is connected to the control inputs of a memory element, an analog multiplexer and shaper recording signal, the input control memory of the element of storage is connected to the output of the shaper of the recording signal, information input-output with information the output-input of an analog multiplexer, the input-output of which is the inputs-outputs of the second drug selector.

Images